Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted APOC3 antisense oligonucleotide

Familial chylomicronemia syndrome (FCS) is a rare, typically debilitating genetic disorder of extreme hypertriglyceridemia associated with high triglyceride levels and elevated risk for recurrent acute pancreatitis. Diagnosis of FCS is frequently delayed due to its rarity, and treatment options are...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Archna Bajaj, Elif A. Oral, Alan Brown, Daniel Gaudet, Veronica J. Alexander, Ewa Karwatowska-Prokopczuk, Seth J. Baum
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2025-12-01
Saila:	American Journal of Preventive Cardiology
Gaiak:	Familial chylomicronemia syndrome Hypertriglyceridemia Olezarsen Antisense oligonucleotide Apolipoprotein C-III Acute pancreatitis
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2666667725004271
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!